JR

Jeff Odell, PharmD, R.Ph.

Executive Director, Market Access at Provention Bio

Jeff Odell, PharmD, R.Ph. is an experienced healthcare professional with a diverse background in market access and pharmaceutical management. Jeff currently serves as the Executive Director of Market Access at Provention Bio. Prior to this, they worked as the Director of National Accounts Market Access & Government Affairs at Ultragenyx Pharmaceutical Inc, leading the development and analysis of market access strategies for rare and ultra-rare disease products. Jeff also served as the Director of Strategic Accounts at ZS Pharma, where they were responsible for establishing and maintaining access for hyperkalemia products with national payers. Jeff has also held roles at Avanir Pharmaceuticals, Humana, Novartis Oncology, Amgen, Schering-Plough Pharmaceuticals, and Scott & White Healthcare, where they gained experience in formulary access strategies, contracting, and account management. Jeff holds a Doctor of Pharmacy degree and is a Registered Pharmacist.

Jeff Odell, PharmD, R.Ph. holds a Doctor of Pharmacy Degree (PharmD) from the University of Oklahoma Health Sciences Center, where they also obtained a Bachelor of Science Degree (BS) in Pharmacy. Jeff is a licensed pharmacist by the Texas State Board of Pharmacy. No specific details regarding the start or end years of their education or the month and year of their certification are provided.

Location

Belton, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Provention Bio

Clinical-stage biopharma company focused on the interception and prevention of immune-mediated disease including type 1 diabetes, celiac disease, and lupus.


Industries

Employees

51-200

Links